Update on GPCR-based targets for the development of novel antidepressants
Sign Up to like & getrecommendations! Published in 2021 at "Molecular Psychiatry"
DOI: 10.1038/s41380-021-01040-1
Abstract: Traditional antidepressants largely interfere with monoaminergic transport or degradation systems, taking several weeks to have their therapeutic actions. Moreover, a large proportion of depressed patients are resistant to these therapies. Several atypical antidepressants have been… read more here.
Keywords: based targets; gpcr based; update gpcr; development ... See more keywords